Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hong Kong Science and Technology Parks Corporation (HKSTP) is the largest innovation ecosystem builder in Hong Kong. Established in 2001 by the government as a statutory body, it manages multiple campuses—including the flagship Hong Kong Science Park—and provides infrastructure plus value-added services for over 2,000 technology companies across sectors such as biotech/life sciences/healthtech. It plays a pivotal role in nurturing startups through incubation programs and facilitating translational research with global partners. In recent years it has deepened its focus on biomedical technology—supporting world-class R&D clusters in health sciences—and has formed strategic partnerships with leading biotech firms to advance precision medicine and AI-driven life science research. The corporation does not develop drugs or devices itself but enables hundreds of pipeline programs via its community of resident enterprises.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hong Kong Science and Technology Parks Corporation.